{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:49:13Z","timestamp":1789235353290,"version":"build-2803163510"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Engineering Research Board (SERB) of the Department of Science and Technology (DST), Government of India","award":["SRG\/2022\/001239"],"award-info":[{"award-number":["SRG\/2022\/001239"]}]},{"name":"Science and Engineering Research Board (SERB) of the Department of Science and Technology (DST), Government of India","award":["SRG\/2022\/001239"],"award-info":[{"award-number":["SRG\/2022\/001239"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-01949-x","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T05:47:25Z","timestamp":1741326445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Deciphering the metabolic landscape of colorectal cancer through the lens of AhR-mediated intestinal inflammation"],"prefix":"10.1007","volume":"16","author":[{"given":"Jasmine","family":"Swain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Preeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul Anand","family":"Bajoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Ward Gahlawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Nikhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya R.","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"3","key":"1949_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"1949_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101174","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021. https:\/\/doi.org\/10.1016\/j.tranon.2021.101174.","journal-title":"Transl Oncol"},{"issue":"12","key":"1949_CR3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2468-1253(19)30329-2","volume":"4","author":"MG Guren","year":"2019","unstructured":"Guren MG. The global challenge of colorectal cancer. Lancet Gastroenterol Hepatol. 2019;4(12):894\u20135. https:\/\/doi.org\/10.1016\/S2468-1253(19)30329-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1949_CR4","doi-asserted-by":"publisher","unstructured":"MG Guren, 2019 \u201cThe global challenge of colorectal cancer\u201d lancet Gastroenterol Hepatol https:\/\/doi.org\/10.1016\/S2468-1253(19)30329-2.","DOI":"10.1016\/S2468-1253(19)30329-2"},{"issue":"3","key":"1949_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145\u201364. https:\/\/doi.org\/10.3322\/caac.21601.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1949_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1949_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.5217\/ir.2019.00021","volume":"17","author":"MC Wong","year":"2019","unstructured":"Wong MC, Ding H, Wang J, Chan PS, Huang J. Prevalence and risk factors of colorectal cancer in Asia. Intest Res. 2019;17(3):317\u201329. https:\/\/doi.org\/10.5217\/ir.2019.00021.","journal-title":"Intest Res"},{"key":"1949_CR8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e16084","author":"V Mathew Thomas","year":"2020","unstructured":"Mathew Thomas V, et al. Trends in colorectal cancer incidence in India. J Clin Oncol. 2020. https:\/\/doi.org\/10.1200\/JCO.2020.38.15_suppl.e16084.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1949_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5114\/pg.2018.81072","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89\u2013103. https:\/\/doi.org\/10.5114\/pg.2018.81072.","journal-title":"Prz Gastroenterol"},{"key":"1949_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6020031","author":"U Testa","year":"2018","unstructured":"Testa U, Pelosi E, Castelli G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med Sci. 2018. https:\/\/doi.org\/10.3390\/medsci6020031.","journal-title":"Med Sci"},{"issue":"4","key":"1949_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11888-017-0373-6","volume":"13","author":"AG Long","year":"2017","unstructured":"Long AG, Lundsmith ET, Hamilton KE. Inflammation and colorectal cancer. Curr Colorectal Cancer Rep. 2017;13(4):341\u201351. https:\/\/doi.org\/10.1007\/s11888-017-0373-6.","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"6","key":"1949_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1586\/17474124.2015.1003208","volume":"9","author":"A Parian","year":"2015","unstructured":"Parian A, Lazarev M. Who and how to screen for cancer in at-risk inflammatory bowel disease patients. Expert Rev Gastroenterol Hepatol. 2015;9(6):731\u201346. https:\/\/doi.org\/10.1586\/17474124.2015.1003208.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1949_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312739","author":"S Frigerio","year":"2021","unstructured":"Frigerio S, Lartey DA, D\u2019Haens GR, Grootjans J. The role of the immune system in IBD-associated colorectal cancer: from pro to anti-tumorigenic mechanisms. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222312739.","journal-title":"Int J Mol Sci"},{"issue":"01","key":"1949_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2576-1471.1000104","volume":"01","author":"X Hou","year":"2016","unstructured":"Hou X, et al. Signaling pathways that facilitate chronic inflammation-induced carcinogenesis. J Cell Signal. 2016;01(01):1\u20139. https:\/\/doi.org\/10.4172\/2576-1471.1000104.","journal-title":"J Cell Signal"},{"key":"1949_CR15","doi-asserted-by":"publisher","first-page":"1328606","DOI":"10.3389\/fonc.2024.1328606","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhang Y, Liao Z, Huang M, Shui X. The potential of aryl hydrocarbon receptor as receptors for metabolic changes in tumors. Front Oncol. 2024;14:1328606. https:\/\/doi.org\/10.3389\/fonc.2024.1328606.","journal-title":"Front Oncol"},{"issue":"1","key":"1949_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1871530320666200909092908","volume":"21","author":"S Muthusami","year":"2021","unstructured":"Muthusami S, et al. Role of inflammation in the development of colorectal cancer. Endocr Metab Immune Disord Drug Targets. 2021;21(1):77\u201390. https:\/\/doi.org\/10.2174\/1871530320666200909092908.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1949_CR17","volume-title":"Chapter Five - Tumor-Elicited Inflammation and Colorectal Cancer","author":"K Wang","year":"2015","unstructured":"Wang K, Karin M. Chapter Five - Tumor-Elicited Inflammation and Colorectal Cancer. Cambridge: Academic Press; 2015."},{"issue":"31","key":"1949_CR18","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.3748\/wjg.v25.i31.4383","volume":"25","author":"AE Tuomisto","year":"2019","unstructured":"Tuomisto AE, M\u00e4kinen MJ, V\u00e4yrynen JP. Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance. World J Gastroenterol. 2019;25(31):4383\u2013404. https:\/\/doi.org\/10.3748\/wjg.v25.i31.4383.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1949_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/08820139.2018.1480030","volume":"47","author":"J Spacek","year":"2018","unstructured":"Spacek J, et al. Immunological examination of peripheral blood in patients with colorectal cancer compared to healthy controls. Immunol Invest. 2018;47(7):643\u201353. https:\/\/doi.org\/10.1080\/08820139.2018.1480030.","journal-title":"Immunol Invest"},{"key":"1949_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116188","author":"AM Burgos-Molina","year":"2024","unstructured":"Burgos-Molina AM, T\u00e9llez Santana T, Redondo M, Bravo Romero MJ. The crucial role of inflammation and the immune system in colorectal cancer carcinogenesis: a comprehensive perspective. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25116188.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1949_CR21","doi-asserted-by":"publisher","first-page":"5126048","DOI":"10.1155\/2017\/5126048","volume":"2017","author":"C Luo","year":"2017","unstructured":"Luo C, Zhang H. The role of proinflammatory pathways in the pathogenesis of colitis-associated colorectal cancer. Mediators Inflamm. 2017;2017(1):5126048. https:\/\/doi.org\/10.1155\/2017\/5126048.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"1949_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3934\/allergy.2019.1.13","volume":"3","author":"DP McKernan","year":"2019","unstructured":"McKernan DP. Toll-like receptors and immune cell crosstalk in the intestinal epithelium. AIMS Allergy Immunol. 2019;3(1):13\u201331. https:\/\/doi.org\/10.3934\/allergy.2019.1.13.","journal-title":"AIMS Allergy Immunol"},{"key":"1949_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00386","author":"R McClure","year":"2014","unstructured":"McClure R, Massari P. TLR-dependent human mucosal epithelial cell responses to microbial pathogens. Front Immunol. 2014. https:\/\/doi.org\/10.3389\/fimmu.2014.00386.","journal-title":"Front Immunol"},{"issue":"9","key":"1949_CR24","doi-asserted-by":"publisher","first-page":"G769","DOI":"10.1152\/ajpgi.00399.2013","volume":"306","author":"G Aviello","year":"2014","unstructured":"Aviello G, Corr SC, Johnston DGW, O\u2019Neill LAJ, Fallon PG. MyD88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice. Am J Physiol Liver Physiol. 2014;306(9):G769\u201378. https:\/\/doi.org\/10.1152\/ajpgi.00399.2013.","journal-title":"Am J Physiol Liver Physiol"},{"key":"1949_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ebiom.2018.08.040","volume":"36","author":"Y Li","year":"2018","unstructured":"Li Y, et al. COX-2\u2013PGE2 signaling impairs intestinal epithelial regeneration and associates with TNF inhibitor responsiveness in ulcerative colitis. EBioMedicine. 2018;36:497\u2013507. https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.040.","journal-title":"EBioMedicine"},{"issue":"3","key":"1949_CR26","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/j.gastro.2006.06.017","volume":"131","author":"M Fukata","year":"2006","unstructured":"Fukata M, et al. Cox-2 is regulated by toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology. 2006;131(3):862\u201377. https:\/\/doi.org\/10.1053\/j.gastro.2006.06.017.","journal-title":"Gastroenterology"},{"issue":"10","key":"1949_CR27","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/ibd\/izz149","volume":"25","author":"D Yao","year":"2019","unstructured":"Yao D, Dong M, Dai C, Wu S. Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer. Inflamm Bowel Dis. 2019;25(10):1595\u2013602. https:\/\/doi.org\/10.1093\/ibd\/izz149.","journal-title":"Inflamm Bowel Dis"},{"key":"1949_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Signal Transduct Target Ther"},{"key":"1949_CR29","unstructured":"M. Patel, \u201cThe role of the non-canonical NF-$\u03ba$B pathway in colorectal cancer,\u201d 2020. https:\/\/api.semanticscholar.org\/CorpusID:226122013"},{"issue":"9","key":"1949_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"S-C Sun","year":"2017","unstructured":"Sun S-C. The non-canonical NF-\u03baB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17(9):545\u201358. https:\/\/doi.org\/10.1038\/nri.2017.52.","journal-title":"Nat Rev Immunol"},{"key":"1949_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071670","author":"J Borowczak","year":"2022","unstructured":"Borowczak J, et al. The Role of inflammatory cytokines in the pathogenesis of colorectal carcinoma\u2014recent findings and review. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10071670.","journal-title":"Biomedicines"},{"key":"1949_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8080236","author":"C Buhrmann","year":"2020","unstructured":"Buhrmann C, et al. Targeting NF-\u03baB signaling by calebin a, a compound of turmeric, in multicellular Tumor microenvironment: potential role of apoptosis induction in CRC cells. Biomedicines. 2020. https:\/\/doi.org\/10.3390\/biomedicines8080236.","journal-title":"Biomedicines"},{"key":"1949_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093062","author":"T Hirano","year":"2020","unstructured":"Hirano T, Hirayama D, Wagatsuma K, Yamakawa T, Yokoyama Y, Nakase H. Immunological mechanisms in inflammation-associated colon carcinogenesis. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21093062.","journal-title":"Int J Mol Sci"},{"issue":"23","key":"1949_CR34","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.18632\/oncotarget.16343","volume":"8","author":"A Jana","year":"2017","unstructured":"Jana A, et al. NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway. Oncotarget. 2017;8(23):37377\u201393. https:\/\/doi.org\/10.18632\/oncotarget.16343.","journal-title":"Oncotarget"},{"key":"1949_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/130981","volume":"2014","author":"H Yang","year":"2014","unstructured":"Yang H, et al. Involvement of NF-\u03baB\/IL-6 pathway in the processing of colorectal carcinogenesis in colitis mice. Int J Inflam. 2014;2014: 130981. https:\/\/doi.org\/10.1155\/2014\/130981.","journal-title":"Int J Inflam"},{"issue":"8","key":"1949_CR36","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.7150\/ijms.44439","volume":"17","author":"J Sheng","year":"2020","unstructured":"Sheng J, Sun H, Yu F-B, Li B, Zhang Y, Zhu Y-T. The role of cyclooxygenase-2 in colorectal cancer. Int J Med Sci. 2020;17(8):1095\u2013101. https:\/\/doi.org\/10.7150\/ijms.44439.","journal-title":"Int J Med Sci"},{"issue":"1","key":"1949_CR37","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1038\/s41598-018-20572-1","volume":"8","author":"J Ohtsuka","year":"2018","unstructured":"Ohtsuka J, Oshima H, Ezawa I, Abe R, Oshima M, Ohki R. Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers. Sci Rep. 2018;8(1):2291. https:\/\/doi.org\/10.1038\/s41598-018-20572-1.","journal-title":"Sci Rep"},{"key":"1949_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.biomaterials.2018.04.001","volume":"170","author":"X Yue","year":"2018","unstructured":"Yue X, Nguyen TD, Zellmer V, Zhang S, Zorlutuna P. Stromal cell-laden 3D hydrogel microwell arrays as tumor microenvironment model for studying stiffness dependent stromal cell-cancer interactions. Biomaterials. 2018;170:37\u201348. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.04.001.","journal-title":"Biomaterials"},{"key":"1949_CR39","doi-asserted-by":"publisher","first-page":"13023","DOI":"10.2147\/OTT.S278013","volume":"13","author":"Y Lin","year":"2020","unstructured":"Lin Y, et al. Progress in understanding the IL-6\/STAT3 pathway in colorectal cancer. Onco Targets Ther. 2020;13:13023\u201332. https:\/\/doi.org\/10.2147\/OTT.S278013.","journal-title":"Onco Targets Ther"},{"key":"1949_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/membranes11050312","author":"M Turano","year":"2021","unstructured":"Turano M, Cammarota F, Duraturo F, Izzo P, De Rosa M. A Potential Role of IL-6\/IL-6R in the Development and Management of Colon Cancer. Membranes. 2021. https:\/\/doi.org\/10.3390\/membranes11050312.","journal-title":"Membranes"},{"key":"1949_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.coi.2015.02.008","volume":"34","author":"C Garbers","year":"2015","unstructured":"Garbers C, Aparicio-Siegmund S, Rose-John S. The IL-6\/gp130\/STAT3 signaling axis: recent advances towards specific inhibition. Curr Opin Immunol. 2015;34:75\u201382. https:\/\/doi.org\/10.1016\/j.coi.2015.02.008.","journal-title":"Curr Opin Immunol"},{"key":"1949_CR42","volume-title":"\u201cInflammation and Cancer","author":"C Garbers","year":"2018","unstructured":"Garbers C, Rose-John S. \u201cInflammation and Cancer. New York NY: Springer, New York; 2018."},{"issue":"1","key":"1949_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","volume":"16","author":"MM Zegeye","year":"2018","unstructured":"Zegeye MM, et al. Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells. Cell Commun Signal. 2018;16(1):55. https:\/\/doi.org\/10.1186\/s12964-018-0268-4.","journal-title":"Cell Commun Signal"},{"key":"1949_CR44","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-GMB-2018-0160","author":"S Arshad","year":"2020","unstructured":"Arshad S, et al. Targeting STAT-3 signaling pathway in cancer for development of novel drugs: advancements and challenges. Genet Mol Biol. 2020. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2018-0160.","journal-title":"Genet Mol Biol"},{"issue":"46","key":"1949_CR45","doi-asserted-by":"publisher","first-page":"75013","DOI":"10.18632\/oncotarget.12601","volume":"7","author":"M Thomsen","year":"2016","unstructured":"Thomsen M, et al. Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer. Oncotarget. 2016;7(46):75013\u201322. https:\/\/doi.org\/10.18632\/oncotarget.12601.","journal-title":"Oncotarget"},{"issue":"4","key":"1949_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/carcin\/bgv017","volume":"36","author":"H Liu","year":"2015","unstructured":"Liu H, et al. Aberrantly expressed Fra-1 by IL-6\/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial\u2013mesenchymal transition. Carcinogenesis. 2015;36(4):459\u201368. https:\/\/doi.org\/10.1093\/carcin\/bgv017.","journal-title":"Carcinogenesis"},{"issue":"8","key":"1949_CR47","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/1078-0432.CCR-13-2200","volume":"20","author":"E Angevin","year":"2014","unstructured":"Angevin E, et al. A Phase I\/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors. Clin Cancer Res. 2014;20(8):2192\u2013204. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2200.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1949_CR48","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.molonc.2015.02.012","volume":"9","author":"L Brambilla","year":"2015","unstructured":"Brambilla L, et al. Hitting the right spot: mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal transducer and activator of Transcription 3 (STAT3). Mol Oncol. 2015;9(6):1194\u2013206. https:\/\/doi.org\/10.1016\/j.molonc.2015.02.012.","journal-title":"Mol Oncol"},{"issue":"5","key":"1949_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1615\/critrevimmunol.2023050360","volume":"43","author":"D Iraji","year":"2023","unstructured":"Iraji D, Oftedal BE, Wolff ASB. Th17 cells: orchestrators of mucosal inflammation and potential therapeutic targets. Crit Rev Immunol. 2023;43(5):25\u201352. https:\/\/doi.org\/10.1615\/critrevimmunol.2023050360.","journal-title":"Crit Rev Immunol"},{"issue":"4","key":"1949_CR50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.smim.2013.10.021","volume":"25","author":"MS Sundrud","year":"2013","unstructured":"Sundrud MS, Trivigno C. Identity crisis of Th17 cells: many forms, many functions, many questions. Semin Immunol. 2013;25(4):263\u201372. https:\/\/doi.org\/10.1016\/j.smim.2013.10.021.","journal-title":"Semin Immunol"},{"key":"1949_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.12.021","author":"S Razi","year":"2019","unstructured":"Razi S, Baradaran Noveiry B, Keshavarz-Fathi M, Rezaei N. IL-17 and colorectal cancer: from carcinogenesis to treatment. Cytokine. 2019. https:\/\/doi.org\/10.1016\/j.cyto.2018.12.021.","journal-title":"Cytokine"},{"issue":"12","key":"1949_CR52","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.autrev.2014.08.019","volume":"13","author":"RP Singh","year":"2014","unstructured":"Singh RP, et al. Th17 cells in inflammation and autoimmunity. Autoimmun Rev. 2014;13(12):1174\u201381. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.019.","journal-title":"Autoimmun Rev"},{"key":"1949_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01002","author":"G Cui","year":"2019","unstructured":"Cui G. TH9, TH17, and TH22 cell subsets and their main cytokine products in the pathogenesis of colorectal cancer. Front Oncol. 2019. https:\/\/doi.org\/10.3389\/fonc.2019.01002.","journal-title":"Front Oncol"},{"key":"1949_CR54","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101921-045939","author":"W Chen","year":"2023","unstructured":"Chen W. TGF-\u03b2 Regulation of T Cells. Annu Rev Immunol. 2023. https:\/\/doi.org\/10.1146\/annurev-immunol-101921-045939.","journal-title":"Annu Rev Immunol"},{"key":"1949_CR55","first-page":"2941","volume":"9","author":"X-W Chen","year":"2015","unstructured":"Chen X-W, Zhou S-F. NF- \u03ba B axis, and tumorigenesis. Drug Des Devel Ther. 2015;9:2941\u20136.","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"1949_CR56","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3892\/mmr.2014.2824","volume":"11","author":"J Yu","year":"2015","unstructured":"Yu J, et al. Interleukin-21 promotes the development of ulcerative colitis and regulates the proliferation and secretion of follicular T helper cells in the colitides microenvironment. Mol Med Rep. 2015;11(2):1049\u201356. https:\/\/doi.org\/10.3892\/mmr.2014.2824.","journal-title":"Mol Med Rep"},{"key":"1949_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-3-030-55617-4_5","volume":"1290","author":"R Jiang","year":"2021","unstructured":"Jiang R, Sun B. IL-22 signaling in the tumor microenvironment. Adv Exp Med Biol. 2021;1290:81\u20138. https:\/\/doi.org\/10.1007\/978-3-030-55617-4_5.","journal-title":"Adv Exp Med Biol"},{"key":"1949_CR58","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.3389\/fimmu.2020.02148","volume":"11","author":"T Arshad","year":"2020","unstructured":"Arshad T, Mansur F, Palek R, Manzoor S, Liska V. A double edged sword role of interleukin-22 in wound healing and tissue regeneration. Front Immunol. 2020;11:2148. https:\/\/doi.org\/10.3389\/fimmu.2020.02148.","journal-title":"Front Immunol"},{"issue":"3","key":"1949_CR59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192195","volume":"217","author":"ME Keir","year":"2020","unstructured":"Keir ME, Yi T, Lu TT, Ghilardi N. The role of IL-22 in intestinal health and disease. J Exp Med. 2020;217(3): e20192195. https:\/\/doi.org\/10.1084\/jem.20192195.","journal-title":"J Exp Med"},{"key":"1949_CR60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.smim.2017.09.006","volume":"32","author":"J Chen","year":"2017","unstructured":"Chen J, Pitmon E, Wang K. Microbiome, inflammation and colorectal cancer. Semin Immunol. 2017;32:43\u201353. https:\/\/doi.org\/10.1016\/j.smim.2017.09.006.","journal-title":"Semin Immunol"},{"key":"1949_CR61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cotox.2017.02.001","volume":"2","author":"L Zhang","year":"2017","unstructured":"Zhang L, Nichols RG, Patterson AD. The aryl hydrocarbon receptor as a moderator of host-microbiota communication. Curr Opin Toxicol. 2017;2:30\u20135. https:\/\/doi.org\/10.1016\/j.cotox.2017.02.001.","journal-title":"Curr Opin Toxicol"},{"issue":"3","key":"1949_CR62","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211\u20138. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001.","journal-title":"Trends Biochem Sci"},{"key":"1949_CR63","doi-asserted-by":"publisher","DOI":"10.1177\/1010428320965284","author":"P Farhadi","year":"2020","unstructured":"Farhadi P, Yarani R, Dokaneheifard S, Mansouri K. \u201cThe emerging role of targeting cancer metabolism for cancer therapy. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2020. https:\/\/doi.org\/10.1177\/1010428320965284.","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"key":"1949_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031155","author":"J Gyamfi","year":"2022","unstructured":"Gyamfi J, Kim J, Choi J. Cancer as a metabolic disorder. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23031155.","journal-title":"Int J Mol Sci"},{"key":"1949_CR65","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ebiom.2019.05.015","volume":"44","author":"W Peng","year":"2019","unstructured":"Peng W, Huang W, Ge X, Xue L, Zhao W, Xue J. Type I\u03b3 phosphatidylinositol phosphate kinase promotes tumor growth by facilitating Warburg effect in colorectal cancer. EBioMedicine. 2019;44:375\u201386. https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.015.","journal-title":"EBioMedicine"},{"key":"1949_CR66","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2802037","author":"J Zhong","year":"2023","unstructured":"Zhong J, et al. To investigate the occurrence and development of colorectal cancer based on the PI3K\/AKT\/mTOR signaling pathway. Front Biosci. 2023. https:\/\/doi.org\/10.31083\/j.fbl2802037.","journal-title":"Front Biosci"},{"issue":"1","key":"1949_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12957-016-0769-9","volume":"14","author":"C Li","year":"2016","unstructured":"Li C, Zhang G, Zhao L, Ma Z, Chen H. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer. World J Surg Oncol. 2016;14(1):15. https:\/\/doi.org\/10.1186\/s12957-016-0769-9.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"1949_CR68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcb.30347","volume":"124","author":"D Chen","year":"2023","unstructured":"Chen D, et al. Lipid metabolism reprogramming in colorectal cancer. J Cell Biochem. 2023;124(1):3\u201316. https:\/\/doi.org\/10.1002\/jcb.30347.","journal-title":"J Cell Biochem"},{"key":"1949_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/nu11061368","author":"A Ferrari","year":"2019","unstructured":"Ferrari A, Torrezan GT, Carraro DM, Aguiar Junior S. Association of folate and vitamins involved in the 1-carbon cycle with polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and global DNA methylation in patients with colorectal cancer. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11061368.","journal-title":"Nutrients"},{"key":"1949_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092867","author":"P Lyon","year":"2020","unstructured":"Lyon P, Strippoli V, Fang B, Cimmino L. B vitamins and one-carbon metabolism: implications in human health and disease. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12092867.","journal-title":"Nutrients"},{"issue":"19","key":"1949_CR71","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.7150\/jca.60170","volume":"12","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, et al. Roles of mitochondrial serine hydroxymethyltransferase 2 (SHMT2) in human carcinogenesis. J Cancer. 2021;12(19):5888\u201394. https:\/\/doi.org\/10.7150\/jca.60170.","journal-title":"J Cancer"},{"issue":"1","key":"1949_CR72","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40168-018-0451-2","volume":"6","author":"Z Dai","year":"2018","unstructured":"Dai Z, et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome. 2018;6(1):70. https:\/\/doi.org\/10.1186\/s40168-018-0451-2.","journal-title":"Microbiome"},{"issue":"4","key":"1949_CR73","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","volume":"25","author":"J Wirbel","year":"2019","unstructured":"Wirbel J, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25(4):679\u201389. https:\/\/doi.org\/10.1038\/s41591-019-0406-6.","journal-title":"Nat Med"},{"issue":"10","key":"1949_CR74","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrc.2016.81","volume":"16","author":"M Yang","year":"2016","unstructured":"Yang M, Vousden KH. Serine and one-carbon metabolism in cancer. Nat Rev Cancer. 2016;16(10):650\u201362. https:\/\/doi.org\/10.1038\/nrc.2016.81.","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"1949_CR75","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.1073\/pnas.1307237110","volume":"110","author":"JJ Kamphorst","year":"2013","unstructured":"Kamphorst JJ, et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci. 2013;110(22):8882\u20137. https:\/\/doi.org\/10.1073\/pnas.1307237110.","journal-title":"Proc Natl Acad Sci"},{"key":"1949_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010114","author":"K Kim","year":"2018","unstructured":"Kim K, et al. Ursolic acid induces apoptosis in colorectal cancer cells partially via upregulation of microrna-4500 and inhibition of JAK2\/STAT3 phosphorylation. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms20010114.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1949_CR77","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","volume":"164","author":"CT Hensley","year":"2016","unstructured":"Hensley CT, et al. Metabolic Heterogeneity in Human Lung Tumors. Cell. 2016;164(4):681\u201394. https:\/\/doi.org\/10.1016\/j.cell.2015.12.034.","journal-title":"Cell"},{"issue":"3","key":"1949_CR78","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5114\/wo.2017.70109","volume":"21","author":"D Bazali\u0144ski","year":"2017","unstructured":"Bazali\u0144ski D, Przybek-Mita J, Bara\u0144ska B, Wi\u0119ch P. Marjolin\u2019s ulcer in chronic wounds \u2013 review of available literature. Contemp Oncol Onkol. 2017;21(3):197\u2013202. https:\/\/doi.org\/10.5114\/wo.2017.70109.","journal-title":"Contemp Oncol Onkol"},{"issue":"11","key":"1949_CR79","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","volume":"18","author":"L Chiossone","year":"2018","unstructured":"Chiossone L, Dumas P-Y, Vienne M, Vivier E. Natural killer cells and other innate lymphoid cells in cancer. Nat Rev Immunol. 2018;18(11):671\u201388. https:\/\/doi.org\/10.1038\/s41577-018-0061-z.","journal-title":"Nat Rev Immunol"},{"key":"1949_CR80","volume-title":"Chapter Six - Interplay between inflammation and cancer","author":"R Khandia","year":"2020","unstructured":"Khandia R, Munjal A. Chapter Six - Interplay between inflammation and cancer. Cambridge: Academic Press; 2020."},{"issue":"12","key":"1949_CR81","first-page":"2760","volume":"9","author":"MR Guda","year":"2019","unstructured":"Guda MR, et al. Pleiotropic role of macrophage migration inhibitory factor in cancer. Am J Cancer Res. 2019;9(12):2760\u201373.","journal-title":"Am J Cancer Res"},{"key":"1949_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5098-7","author":"N Kumari","year":"2016","unstructured":"Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2016. https:\/\/doi.org\/10.1007\/s13277-016-5098-7.","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"issue":"1","key":"1949_CR83","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/570653","volume":"2015","author":"C Du","year":"2015","unstructured":"Du C, Bhatia M, Tang SCW, Zhang M, Steiner T. Mediators of inflammation: inflammation in cancer, chronic diseases, and wound healing. Mediators Inflamm. 2015;2015(1): 570653. https:\/\/doi.org\/10.1155\/2015\/570653.","journal-title":"Mediators Inflamm"},{"key":"1949_CR84","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.314037","author":"L Sun","year":"2020","unstructured":"Sun L, Yang X, Yuan Z, Wang H. Metabolic reprogramming in immune response and tissue inflammation. Arterioscler Thromb Vasc Biol. 2020. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314037.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"1949_CR85","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759\u201371. https:\/\/doi.org\/10.1038\/nrc3611.","journal-title":"Nat Rev Cancer"},{"key":"1949_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.768861","author":"KW Hon","year":"2021","unstructured":"Hon KW, Zainal Abidin SA, Othman I, Naidu R. The crosstalk between signaling pathways and cancer metabolism in colorectal cancer. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.768861.","journal-title":"Front Pharmacol"},{"key":"1949_CR87","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.freeradbiomed.2014.11.012","volume":"79","author":"C-F Chang","year":"2015","unstructured":"Chang C-F, Diers AR, Hogg N. Cancer cell metabolism and the modulating effects of nitric oxide. Free Radic Biol Med. 2015;79:324\u201336. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.11.012.","journal-title":"Free Radic Biol Med"},{"key":"1949_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2023.100077","author":"D Guo","year":"2023","unstructured":"Guo D, Meng Y, Jiang X, Lu Z. Hexokinases in cancer and other pathologies. Cell Insight. 2023. https:\/\/doi.org\/10.1016\/j.cellin.2023.100077.","journal-title":"Cell Insight"},{"issue":"22","key":"1949_CR89","doi-asserted-by":"publisher","first-page":"18891","DOI":"10.18632\/oncotarget.3783","volume":"6","author":"YY Zaytseva","year":"2015","unstructured":"Zaytseva YY, et al. Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration. Oncotarget. 2015;6(22):18891\u2013904. https:\/\/doi.org\/10.18632\/oncotarget.3783.","journal-title":"Oncotarget"},{"issue":"2","key":"1949_CR90","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5009\/gnl220260","volume":"17","author":"P Niekamp","year":"2023","unstructured":"Niekamp P, Kim CH. Microbial metabolite dysbiosis and colorectal cancer. Gut Liver. 2023;17(2):190\u2013203. https:\/\/doi.org\/10.5009\/gnl220260.","journal-title":"Gut Liver"},{"issue":"10","key":"1949_CR91","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1124\/dmd.115.064246","volume":"43","author":"TD Hubbard","year":"2015","unstructured":"Hubbard TD, Murray IA, Perdew GH. Indole and tryptophan metabolism: endogenous and dietary routes to ah receptor activation. Drug Metab Dispos. 2015;43(10):1522\u201335. https:\/\/doi.org\/10.1124\/dmd.115.064246.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"1949_CR92","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1124\/pr.113.007823","volume":"65","author":"FJ Quintana","year":"2013","unstructured":"Quintana FJ, Sherr DH. Aryl hydrocarbon receptor control of adaptive immunity. Pharmacol Rev. 2013;65(4):1148\u201361. https:\/\/doi.org\/10.1124\/pr.113.007823.","journal-title":"Pharmacol Rev"},{"key":"1949_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103049","volume":"138","author":"W Huang","year":"2023","unstructured":"Huang W, et al. The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis. J Autoimmun. 2023;138: 103049. https:\/\/doi.org\/10.1016\/j.jaut.2023.103049.","journal-title":"J Autoimmun"},{"issue":"3","key":"1949_CR94","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/jb\/mvx074","volume":"163","author":"I Kudo","year":"2018","unstructured":"Kudo I, et al. The regulation mechanisms of AhR by molecular chaperone complex. J Biochem. 2018;163(3):223\u201332. https:\/\/doi.org\/10.1093\/jb\/mvx074.","journal-title":"J Biochem"},{"issue":"12","key":"1949_CR95","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1021\/ci5005459","volume":"54","author":"R Nuti","year":"2014","unstructured":"Nuti R, et al. Ligand binding and functional selectivity of L-tryptophan metabolites at the mouse aryl hydrocarbon receptor (mAhR). J Chem Inf Model. 2014;54(12):3373\u201383. https:\/\/doi.org\/10.1021\/ci5005459.","journal-title":"J Chem Inf Model"},{"key":"1949_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopen.2018.05.001","volume":"7","author":"L Larigot","year":"2018","unstructured":"Larigot L, Juricek L, Dairou J, Coumoul X. AhR signaling pathways and regulatory functions. Biochim Open. 2018;7:1\u20139. https:\/\/doi.org\/10.1016\/j.biopen.2018.05.001.","journal-title":"Biochim Open"},{"issue":"2","key":"1949_CR97","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2174\/1389200013338603","volume":"2","author":"Q Ma","year":"2001","unstructured":"Ma Q. Induction of CYP1A1. the AhR\/DRE paradigm: transcription, receptor regulation, and expanding biological roles. Curr Drug Metab. 2001;2(2):149\u201364. https:\/\/doi.org\/10.2174\/1389200013338603.","journal-title":"Curr Drug Metab"},{"issue":"6","key":"1949_CR98","doi-asserted-by":"publisher","first-page":"C1078","DOI":"10.1152\/ajpcell.00493.2019","volume":"318","author":"T Guarnieri","year":"2020","unstructured":"Guarnieri T, Abruzzo PM, Bolotta A. More than a cell biosensor: aryl hydrocarbon receptor at the intersection of physiology and inflammation. Am J Physiol Cell Physiol. 2020;318(6):C1078\u201382. https:\/\/doi.org\/10.1152\/ajpcell.00493.2019.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1949_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110445","volume":"99","author":"A Salminen","year":"2022","unstructured":"Salminen A. Mutual antagonism between aryl hydrocarbon receptor and hypoxia-inducible factor-1\u03b1 (AhR\/HIF-1\u03b1) signaling: Impact on the aging process. Cell Signal. 2022;99: 110445. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110445.","journal-title":"Cell Signal"},{"issue":"7640","key":"1949_CR100","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature21080","volume":"542","author":"C Schiering","year":"2017","unstructured":"Schiering C, et al. Feedback control of AHR signalling regulates intestinal immunity. Nature. 2017;542(7640):242\u20135. https:\/\/doi.org\/10.1038\/nature21080.","journal-title":"Nature"},{"issue":"43","key":"1949_CR101","doi-asserted-by":"publisher","first-page":"17609","DOI":"10.1074\/jbc.M117.812974","volume":"292","author":"S Sakurai","year":"2017","unstructured":"Sakurai S, Shimizu T, Ohto U. The crystal structure of the AhRR\u2013ARNT heterodimer reveals the structural basis of the repression of AhR-mediated transcription. J Biol Chem. 2017;292(43):17609\u201316. https:\/\/doi.org\/10.1074\/jbc.M117.812974.","journal-title":"J Biol Chem"},{"issue":"2","key":"1949_CR102","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55(2):324-340.e8. https:\/\/doi.org\/10.1016\/j.immuni.2022.01.006.","journal-title":"Immunity"},{"issue":"1","key":"1949_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kft128","volume":"135","author":"S Safe","year":"2013","unstructured":"Safe S, Lee S-O, Jin U-H. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target. Toxicol Sci. 2013;135(1):1\u201316. https:\/\/doi.org\/10.1093\/toxsci\/kft128.","journal-title":"Toxicol Sci"},{"issue":"12","key":"1949_CR104","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrc3846","volume":"14","author":"IA Murray","year":"2014","unstructured":"Murray IA, Patterson AD, Perdew GH. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat Rev Cancer. 2014;14(12):801\u201314. https:\/\/doi.org\/10.1038\/nrc3846.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1949_CR105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12672-013-0160-z","volume":"5","author":"R Saito","year":"2014","unstructured":"Saito R, et al. Aryl hydrocarbon receptor in breast cancer\u2014a newly defined prognostic marker. Horm Cancer. 2014;5(1):11\u201321. https:\/\/doi.org\/10.1007\/s12672-013-0160-z.","journal-title":"Horm Cancer"},{"key":"1949_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.740704","author":"R Taddese","year":"2021","unstructured":"Taddese R, et al. Streptococcus gallolyticus increases expression and activity of aryl hydrocarbon receptor-dependent CYP1 biotransformation capacity in colorectal epithelial cells. Front Cell Infect Microbiol. 2021. https:\/\/doi.org\/10.3389\/fcimb.2021.740704.","journal-title":"Front Cell Infect Microbiol"},{"key":"1949_CR107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2012692118","author":"JE Kenison","year":"2021","unstructured":"Kenison JE, Wang Z, Yang K, Snyder M, Quintana FJ, Sherr DH. The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation. Proc Natl Acad Sci USA. 2021. https:\/\/doi.org\/10.1073\/pnas.2012692118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1949_CR108","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/19490976.2020.1758008","volume":"11","author":"N Ma","year":"2020","unstructured":"Ma N, He T, Johnston LJ, Ma X. Host-microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling. Gut Microbes. 2020;11(5):1203\u201319. https:\/\/doi.org\/10.1080\/19490976.2020.1758008.","journal-title":"Gut Microbes"},{"issue":"2","key":"1949_CR109","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.yexcr.2016.03.012","volume":"343","author":"T Ikuta","year":"2016","unstructured":"Ikuta T, Kurosumi M, Yatsuoka T, Nishimura Y. Tissue distribution of aryl hydrocarbon receptor in the intestine: Implication of putative roles in tumor suppression. Exp Cell Res. 2016;343(2):126\u201334. https:\/\/doi.org\/10.1016\/j.yexcr.2016.03.012.","journal-title":"Exp Cell Res"},{"issue":"3","key":"1949_CR110","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/cancers7030847","volume":"7","author":"G Xie","year":"2015","unstructured":"Xie G, Raufman J-P. Role of the aryl hydrocarbon receptor in colon neoplasia. Cancers (Basel). 2015;7(3):1436\u201346. https:\/\/doi.org\/10.3390\/cancers7030847.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1949_CR111","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2015.10.014","volume":"370","author":"SM Ronnekleiv-Kelly","year":"2016","unstructured":"Ronnekleiv-Kelly SM, et al. Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells. Cancer Lett. 2016;370(1):91\u20139. https:\/\/doi.org\/10.1016\/j.canlet.2015.10.014.","journal-title":"Cancer Lett"},{"issue":"2","key":"1949_CR112","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3892\/ijmm.2017.3262","volume":"41","author":"Q Wang","year":"2018","unstructured":"Wang Q, et al. Aryl hydrocarbon receptor inhibits inflammation in DSS-induced colitis via the MK2\/p-MK2\/TTP pathway. Int J Mol Med. 2018;41(2):868\u201376. https:\/\/doi.org\/10.3892\/ijmm.2017.3262.","journal-title":"Int J Mol Med"},{"key":"1949_CR113","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.31.1_supplement.790.9","author":"EL Garcia-Villatoro","year":"2017","unstructured":"Garcia-Villatoro EL, et al. The Aryl Hydrocarbon Receptor is a repressor of colorectal cancer development induced by high-fat diet in mice. FASEB J. 2017. https:\/\/doi.org\/10.1096\/fasebj.31.1_supplement.790.9.","journal-title":"FASEB J"},{"issue":"3","key":"1949_CR114","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/08830185.2021.1954638","volume":"41","author":"M Ala","year":"2022","unstructured":"Ala M. Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system. Int Rev Immunol. 2022;41(3):326\u201345. https:\/\/doi.org\/10.1080\/08830185.2021.1954638.","journal-title":"Int Rev Immunol"},{"key":"1949_CR115","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cotox.2017.01.012","volume":"2","author":"S Safe","year":"2017","unstructured":"Safe S, Cheng Y, Jin U-H. The aryl hydrocarbon receptor (AhR) as a drug target for cancer chemotherapy. Curr Opin Toxicol. 2017;2:24\u20139. https:\/\/doi.org\/10.1016\/j.cotox.2017.01.012.","journal-title":"Curr Opin Toxicol"},{"key":"1949_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020752","author":"A Paris","year":"2021","unstructured":"Paris A, Tardif N, Galibert M-D, Corre S. AhR and cancer: from gene profiling to targeted therapy. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22020752.","journal-title":"Int J Mol Sci"},{"key":"1949_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.710165","author":"S Wang","year":"2021","unstructured":"Wang S, et al. Fusobacterium nucleatum acts as a pro-carcinogenic bacterium in colorectal cancer: from association to causality. Front Cell Dev Biol. 2021. https:\/\/doi.org\/10.3389\/fcell.2021.710165.","journal-title":"Front Cell Dev Biol"},{"key":"1949_CR118","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aba9157","author":"MA Casasanta","year":"2020","unstructured":"Casasanta MA, et al. Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration. Sci Signal. 2020. https:\/\/doi.org\/10.1126\/scisignal.aba9157.","journal-title":"Sci Signal"},{"issue":"5","key":"1949_CR119","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1053\/j.gastro.2021.08.003","volume":"161","author":"Y Cao","year":"2021","unstructured":"Cao Y, et al. Enterotoxigenic bacteroidesfragilis promotes intestinal inflammation and malignancy by inhibiting exosome-packaged miR-149-3p. Gastroenterology. 2021;161(5):1552-1566.e12. https:\/\/doi.org\/10.1053\/j.gastro.2021.08.003.","journal-title":"Gastroenterology"},{"key":"1949_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12061111","author":"M Sadeghi","year":"2024","unstructured":"Sadeghi M, Mestivier D, Sobhani I. Contribution of pks+ Escherichia coli (E coli) to Colon Carcinogenesis. Microorganisms. 2024. https:\/\/doi.org\/10.3390\/microorganisms12061111.","journal-title":"Microorganisms"},{"issue":"6428","key":"1949_CR121","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.aaw5475","volume":"363","author":"RM Bleich","year":"2019","unstructured":"Bleich RM, Arthur JC. Revealing a microbial carcinogen. Science. 2019;363(6428):689\u201390. https:\/\/doi.org\/10.1126\/science.aaw5475.","journal-title":"Science"},{"issue":"12","key":"1949_CR122","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrgastro.2016.165","volume":"13","author":"SJD O\u2019Keefe","year":"2016","unstructured":"O\u2019Keefe SJD. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol. 2016;13(12):691\u2013706. https:\/\/doi.org\/10.1038\/nrgastro.2016.165.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1949_CR123","doi-asserted-by":"publisher","first-page":"1788899","DOI":"10.1080\/19490976.2020.1788899","volume":"12","author":"F Dong","year":"2020","unstructured":"Dong F, et al. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes. 2020;12(1):1788899. https:\/\/doi.org\/10.1080\/19490976.2020.1788899.","journal-title":"Gut Microbes"},{"key":"1949_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094644","author":"M Gargaro","year":"2021","unstructured":"Gargaro M, Manni G, Scalisi G, Puccetti P, Fallarino F. Tryptophan metabolites at the crossroad of immune-cell interaction via the aryl hydrocarbon receptor: implications for tumor immunotherapy. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094644.","journal-title":"Int J Mol Sci"},{"key":"1949_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7010019","author":"NE Diether","year":"2019","unstructured":"Diether NE, Willing BP. Microbial fermentation of dietary protein: an important factor in diet\u2013microbe\u2013host interaction. Microorganisms. 2019. https:\/\/doi.org\/10.3390\/microorganisms7010019.","journal-title":"Microorganisms"},{"key":"1949_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2017.09.011","author":"CV Ferreira-Halder","year":"2017","unstructured":"Ferreira-Halder CV, de Faria AVS, Andrade SS. Action and function of Faecalibacterium prausnitzii in health and disease. Best Pract Res Clin Gastroenterol. 2017. https:\/\/doi.org\/10.1016\/j.bpg.2017.09.011.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"1949_CR127","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/SLA.0000000000001874","volume":"264","author":"CJ D\u00edaz-D\u00edaz","year":"2016","unstructured":"D\u00edaz-D\u00edaz CJ, et al. The aryl hydrocarbon receptor is a repressor of inflammation-associated colorectal tumorigenesis in mouse. Ann Surg. 2016;264(3):429\u201336. https:\/\/doi.org\/10.1097\/SLA.0000000000001874.","journal-title":"Ann Surg"},{"issue":"3","key":"1949_CR128","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/apm.13206","volume":"130","author":"ALB Bennedsen","year":"2022","unstructured":"Bennedsen ALB, Furbo S, Bjarnsholt T, Raskov H, G\u00f6genur I, Kvich L. The gut microbiota can orchestrate the signaling pathways in colorectal cancer. APMIS. 2022;130(3):121\u201339. https:\/\/doi.org\/10.1111\/apm.13206.","journal-title":"APMIS"},{"issue":"2","key":"1949_CR129","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbcan.2013.05.001","volume":"1836","author":"S Feng","year":"2013","unstructured":"Feng S, Cao Z, Wang X. Role of aryl hydrocarbon receptor in cancer. Biochim Biophys Acta. 2013;1836(2):197\u2013210. https:\/\/doi.org\/10.1016\/j.bbcan.2013.05.001.","journal-title":"Biochim Biophys Acta"},{"key":"1949_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010387","author":"Z Wang","year":"2020","unstructured":"Wang Z, et al. How the AHR became important in cancer the role of chronically active AHR in cancer aggression. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms22010387.","journal-title":"Int J Mol Sci"},{"key":"1949_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115801","volume":"216","author":"JA Holme","year":"2023","unstructured":"Holme JA, et al. Lung cancer associated with combustion particles and fine particulate matter (PM(2.5)) - the roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR). Biochem Pharmacol. 2023;216: 115801. https:\/\/doi.org\/10.1016\/j.bcp.2023.115801.","journal-title":"Biochem Pharmacol"},{"key":"1949_CR132","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fimmu.2018.00286","volume":"9","author":"P Xue","year":"2018","unstructured":"Xue P, Fu J, Zhou Y. The aryl hydrocarbon receptor and tumor immunity. Front Immunol. 2018;9:286. https:\/\/doi.org\/10.3389\/fimmu.2018.00286.","journal-title":"Front Immunol"},{"issue":"9","key":"1949_CR133","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1073\/pnas.1815126116","volume":"116","author":"SP Kubli","year":"2019","unstructured":"Kubli SP, et al. AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer. Proc Natl Acad Sci U S A. 2019;116(9):3604\u201313. https:\/\/doi.org\/10.1073\/pnas.1815126116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1949_CR134","doi-asserted-by":"publisher","first-page":"1095289","DOI":"10.3389\/fphar.2022.1095289","volume":"13","author":"C Sweeney","year":"2022","unstructured":"Sweeney C, Lazennec G, Vogel CFA. Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer. Front Pharmacol. 2022;13:1095289. https:\/\/doi.org\/10.3389\/fphar.2022.1095289.","journal-title":"Front Pharmacol"},{"key":"1949_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/metabo8040086","author":"GE Muku","year":"2018","unstructured":"Muku GE, Murray IA, Esp\u00edn JC, Perdew GH. Urolithin a is a dietary microbiota-derived human aryl hydrocarbon receptor antagonist. Metabolites. 2018. https:\/\/doi.org\/10.3390\/metabo8040086.","journal-title":"Metabolites"},{"key":"1949_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111260","author":"JA Gim\u00e9nez-Bastida","year":"2020","unstructured":"Gim\u00e9nez-Bastida JA, \u00c1vila-G\u00e1lvez M\u00c1, Esp\u00edn JC, Gonz\u00e1lez-Sarr\u00edas A. The gut microbiota metabolite urolithin A but not other relevant urolithins, induces p53-dependent cellular senescence in human colon cancer cells. Food Chem Toxicol. 2020. https:\/\/doi.org\/10.1016\/j.fct.2020.111260.","journal-title":"Food Chem Toxicol"},{"key":"1949_CR137","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-019-02016-2","author":"YI Mohammed Saleem","year":"2020","unstructured":"Mohammed Saleem YI, Albassam H, Selim M. Urolithin A induces prostate cancer cell death in p53-dependent and in p53-independent manner. Eur J Nutr. 2020. https:\/\/doi.org\/10.1007\/s00394-019-02016-2.","journal-title":"Eur J Nutr"},{"issue":"4","key":"1949_CR138","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1039\/C6FO01810F","volume":"8","author":"Z Xue","year":"2017","unstructured":"Xue Z, et al. Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor. Food Funct. 2017;8(4):1414\u201337. https:\/\/doi.org\/10.1039\/C6FO01810F.","journal-title":"Food Funct"},{"key":"1949_CR139","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/832161","volume":"2014","author":"VL Maruthanila","year":"2014","unstructured":"Maruthanila VL, Poornima J, Mirunalini S. Attenuation of carcinogenesis and the mechanism underlying by the influence of Indole-3-carbinol and Its Metabolite 3,3\u2019-Diindolylmethane: a therapeutic marvel. Adv Pharmacol Sci. 2014;2014: 832161. https:\/\/doi.org\/10.1155\/2014\/832161.","journal-title":"Adv Pharmacol Sci"},{"key":"1949_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020457","author":"DM Kopustinskiene","year":"2020","unstructured":"Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as anticancer agents. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12020457.","journal-title":"Nutrients"},{"issue":"4","key":"1949_CR141","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1021\/acs.chemrestox.8b00371","volume":"32","author":"A Mohammadi-Bardbori","year":"2019","unstructured":"Mohammadi-Bardbori A, Omidi M, Arabnezhad M-R. Impact of CH223191-induced mitochondrial dysfunction on Its Aryl hydrocarbon receptor agonistic and antagonistic activities. Chem Res Toxicol. 2019;32(4):691\u20137. https:\/\/doi.org\/10.1021\/acs.chemrestox.8b00371.","journal-title":"Chem Res Toxicol"},{"key":"1949_CR142","doi-asserted-by":"publisher","DOI":"10.1017\/jns.2016.41","volume":"5","author":"AN Panche","year":"2016","unstructured":"Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci. 2016;5: e47. https:\/\/doi.org\/10.1017\/jns.2016.41.","journal-title":"J Nutr Sci"},{"issue":"5","key":"1949_CR143","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10408444.2019.1635987","volume":"49","author":"T Yang","year":"2019","unstructured":"Yang T, Feng Y-L, Chen L, Vaziri ND, Zhao Y-Y. Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor. Crit Rev Toxicol. 2019;49(5):445\u201360. https:\/\/doi.org\/10.1080\/10408444.2019.1635987.","journal-title":"Crit Rev Toxicol"},{"key":"1949_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010028","author":"M Abotaleb","year":"2019","unstructured":"Abotaleb M, et al. Flavonoids in cancer and apoptosis. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11010028.","journal-title":"Cancers"},{"issue":"1","key":"1949_CR145","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40880-017-0217-4","volume":"36","author":"H Amawi","year":"2017","unstructured":"Amawi H, Ashby CRJ, Tiwari AK. Cancer chemoprevention through dietary flavonoids: what\u2019s limiting? Chin J Cancer. 2017;36(1):50. https:\/\/doi.org\/10.1186\/s40880-017-0217-4.","journal-title":"Chin J Cancer"},{"key":"1949_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145025","author":"HM Leclair","year":"2020","unstructured":"Leclair HM, Tardif N, Paris A, Galibert M-D, Corre S. Role of Flavonoids in the prevention of AhR-dependent resistance during treatment with BRAF inhibitors. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21145025.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1949_CR147","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1158\/1940-6207.CAPR-14-0464","volume":"8","author":"GB Lesinski","year":"2015","unstructured":"Lesinski GB, et al. Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells. Cancer Prev Res (Phila). 2015;8(11):1036\u201344. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-14-0464.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"7","key":"1949_CR148","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00204-017-1981-2","volume":"91","author":"SK Kolluri","year":"2017","unstructured":"Kolluri SK, Jin U-H, Safe S. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target. Arch Toxicol. 2017;91(7):2497\u2013513. https:\/\/doi.org\/10.1007\/s00204-017-1981-2.","journal-title":"Arch Toxicol"},{"key":"1949_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105770","volume":"97","author":"MS Khan","year":"2024","unstructured":"Khan MS, Fatima M, Gupta G, Md S, Kesharwani P. Recent progress in zein nanoparticles: a promising approach for advancing cancer therapy. J Drug Deliv Sci Technol. 2024;97: 105770. https:\/\/doi.org\/10.1016\/j.jddst.2024.105770.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1949_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2024.112800","author":"M Sameer Khan","year":"2024","unstructured":"Sameer Khan M, et al. Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: advancements and future perspectives. Eur Polym J. 2024. https:\/\/doi.org\/10.1016\/j.eurpolymj.2024.112800.","journal-title":"Eur Polym J"},{"issue":"11","key":"1949_CR151","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/bies.201300084","volume":"35","author":"EM Palsson-McDermott","year":"2013","unstructured":"Palsson-McDermott EM, O\u2019Neill LAJ. The Warburg effect then and now: from cancer to inflammatory diseases. BioEssays. 2013;35(11):965\u201373. https:\/\/doi.org\/10.1002\/bies.201300084.","journal-title":"BioEssays"},{"issue":"3","key":"1949_CR152","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-019-0106-z","volume":"19","author":"H Lemos","year":"2019","unstructured":"Lemos H, Huang L, Prendergast GC, Mellor AL. Immune control by amino acid catabolism during tumorigenesis and therapy. Nat Rev Cancer. 2019;19(3):162\u201375. https:\/\/doi.org\/10.1038\/s41568-019-0106-z.","journal-title":"Nat Rev Cancer"},{"key":"1949_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065967","author":"M Salla","year":"2023","unstructured":"Salla M, et al. Novel biomarkers for inflammatory bowel disease and colorectal cancer: an interplay between metabolic dysregulation and excessive inflammation. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24065967.","journal-title":"Int J Mol Sci"},{"key":"1949_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10110447","author":"H Nakagawa","year":"2018","unstructured":"Nakagawa H, Hayata Y, Kawamura S, Yamada T, Fujiwara N, Koike K. Lipid metabolic reprogramming in hepatocellular carcinoma. Cancers. 2018. https:\/\/doi.org\/10.3390\/cancers10110447.","journal-title":"Cancers"},{"key":"1949_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188893","author":"S Fu","year":"2023","unstructured":"Fu S, Xu S, Zhang S. The role of amino acid metabolism alterations in pancreatic cancer: from mechanism to application. Biochim Biophys Acta Rev Cancer. 2023. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188893.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1949_CR156","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fonc.2020.00276","volume":"10","author":"JF Fahrmann","year":"2020","unstructured":"Fahrmann JF, Vykoukal JV, Ostrin EJ. Amino acid oncometabolism and immunomodulation of the tumor microenvironment in lung cancer. Front Oncol. 2020;10:276. https:\/\/doi.org\/10.3389\/fonc.2020.00276.","journal-title":"Front Oncol"},{"issue":"10","key":"1949_CR157","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.molmed.2021.07.006","volume":"27","author":"N Joisten","year":"2021","unstructured":"Joisten N, Ruas JL, Braidy N, Guillemin GJ, Zimmer P. The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force? Trends Mol Med. 2021;27(10):946\u201354. https:\/\/doi.org\/10.1016\/j.molmed.2021.07.006.","journal-title":"Trends Mol Med"},{"issue":"3","key":"1949_CR158","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4049\/jimmunol.1601318","volume":"198","author":"IA Bettencourt","year":"2017","unstructured":"Bettencourt IA, Powell JD. Targeting metabolism as a novel therapeutic approach to autoimmunity, inflammation, and transplantation. J Immunol. 2017;198(3):999\u20131005. https:\/\/doi.org\/10.4049\/jimmunol.1601318.","journal-title":"J Immunol"},{"key":"1949_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13111166","author":"Y Hou","year":"2023","unstructured":"Hou Y, Li J, Ying S. Tryptophan metabolism and gut microbiota: a novel regulatory axis integrating the microbiome, immunity, and cancer. Metabolites. 2023. https:\/\/doi.org\/10.3390\/metabo13111166.","journal-title":"Metabolites"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01949-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T05:47:34Z","timestamp":1741326454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01949-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1949"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01949-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}